Published 10 days ago • loading... • Updated 10 days ago

An unloved health-care stock gets a welcome nod in this AI-obsessed market

Summary by CNBC

Leerink analysts lifted J&J shares to a buy equivalent from hold on Wednesday, citing the company's slate of new drugs.

Leerink analysts lifted J&J shares to a buy equivalent from hold on Wednesday, citing the company's slate of new drugs.

10 days ago·United States

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Total News Sources1

Leaning Left1Leaning Right0Center0Last Updated10 days agoBias Distribution

100% Left

100% Left

To view factuality data please Upgrade to Premium

To view ownership data please Upgrade to Vantage

CNBC broke the news in United States 10 days ago on Wednesday, May 13, 2026.

Sources are mostly out of (0)